AstraZeneca Vaxzevria COVID-19 Vaccine from Canada
Vaxzevria uses chimpanzee adenovirus vector expressing SARS-CoV-2 spike for immunity. Retail multi-dose vials qualify under HTS 3002.15.00 immunological products.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Shake well before dose; silicone-free syringes required
• TTS (thrombosis) risk labeling mandatory
• Live vector elements may trigger 3002.30 review